Categories: aggregated

Is Pfizer Buying Arena Pharmaceuticals to Get into the Cannabis Space or Do They Just Want IBS and Digestive Issue Drugs?

Mike Gladstone, global president and general manager of Pfizer Inflammation and Immunology unit, said that the acquisition of Arena is in line with the company’s capabilities and expertise in immunology and inflammatory-related conditions. Over the years, Pfizer has successfully created an innovation engine that develops potential medicines for patients worldwide with chronic and debilitating immuno-inflammatory conditions. The company understands that there is an urgent need to look into other treatment options with high potential, which is where Arena’s cannabinoid-drug pipeline comes in.

Jason

Share
Published by
Jason

Recent Posts

The Red Wall Blocking Marijuana Legalization in America, Real or Imagined?

As the movement for marijuana legalization gains momentum across the United States, a significant barrier…

1 day ago

Autoimmune Conditions Are Rising Fast in American Medicine, Can Cannabis Help?

Conventional treatments prescribed to treat autoimmune conditions are focused on taming inflammation; these usually include…

1 day ago

Ohio Non-Medical Cannabis is available at Verilife

Verilife Non-Medical Cannabis is now available in Ohio. Open to customers 21+ with a valid…

2 days ago

Find Verilife in New York

At Verilife, there's always a stocked selection of top products & new favorites. Find the…

2 days ago

Find Verilife in Illinois

At Verilife, there's always a stocked selection of top products & new favorites. Find the…

2 days ago